(HPQ) HP - NYSE
Sector: Technology | Industry: Computer Hardware | Exchange: NYSE (USA) | Market Cap: 21.491m USD | Total Return: -1.8% in 12m
Avg Turnover: 530M
EPS Trend: -45.9%
Qual. Beats: 2
Rev. Trend: 75.0%
Qual. Beats: 2
Warnings
Altman Z'' -0.60 < 1.0 - financial distress zone
Below Avwap Earnings
Tailwinds
Confidence
HP Inc. (NYSE: HPQ) is a global provider of personal computing, printing, and 3D printing technologies, operating through three segments: Personal Systems, Printing, and Corporate Investments. The Personal Systems segment supplies commercial and consumer desktops, notebooks, workstations, displays, and related hardware, software, and lifecycle services. The Printing segment offers consumer and commercial printer hardware, supplies, and solutions, including graphics, 3D printing, and personalization offerings for commercial and industrial markets. The Corporate Investments segment focuses on business incubation and investment projects. The company serves small- and medium-sized businesses, public sector, and enterprise customers worldwide, and is headquartered in Palo Alto, California, having been founded in 1939 and renamed from Hewlett-Packard Company in October 2015.
HPQ is classified within the Information Technology sector, specifically the Technology Hardware, Storage & Peripherals sub-industry, a segment that traditionally competes with major rivals like Dell and Lenovo in personal computing and with companies such as Canon and Epson in printing. A notable feature of HPs business model is its dual revenue stream combining lower-margin hardware sales (PCs and printers) with higher-margin recurring revenue from consumables such as ink and toner, which is a characteristic of the printer market that helps stabilize cash flow over equipment lifecycles.
- PC revenue grows on AI PC refresh cycle and Windows 11 migration
- Printing supplies margins pressured by secular office printing decline
- Aggressive share buybacks and dividends support earnings per share growth
| Net Income: 2.55b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.09 > 0.02 and ΔFCF/TA 1.95 > 1.0 |
| NWC/Revenue: -10.84% < 20% (prev -13.07%; Δ 2.24% < -1%) |
| CFO/TA 0.11 > 3% & CFO 4.59b > Net Income 2.55b |
| Net Debt (7.16b) to EBITDA (3.92b): 1.83 < 3 |
| Current Ratio: 0.79 > 1.5 & < 3 |
| Outstanding Shares: last quarter (925.0m) vs 12m ago -3.24% < -2% |
| Gross Margin: 20.31% > 18% (prev 21.15%; Δ -0.84% > 0.5%) |
| Asset Turnover: 140.5% > 50% (prev 139.9%; Δ 0.55% > 0%) |
| Interest Coverage Ratio: 6.77 > 6 (EBIT TTM 3.07b / Interest Expense TTM 454.0m) |
| A: -0.14 (Total Current Assets 24.0b - Total Current Liabilities 30.2b) / Total Assets 42.9b |
| B: -0.05 (Retained Earnings -1.96b / Total Assets 42.9b) |
| C: 0.08 (EBIT TTM 3.07b / Avg Total Assets 40.9b) |
| D: -0.00 (Book Value of Equity -144.0m / Total Liabilities 43.1b) |
| Altman-Z'' = -0.60 = B |
| DSRI: 1.35 (Receivables 9.55b/6.71b, Revenue 57.4b/54.3b) |
| GMI: 1.04 (GM 21.15% / 20.31%) |
| AQI: 0.87 (AQ_t 0.34 / AQ_t-1 0.39) |
| SGI: 1.06 (Revenue 57.4b / 54.3b) |
| TATA: -0.05 (NI 2.55b - CFO 4.59b) / TA 42.9b) |
| Beneish M = -2.74 (Cap -4..+1) = A |
As of June 26, 2026, the stock is trading at USD 22.92 with a total of 14,981,819 shares traded. Over the past week, the price has changed by -1.12%, over one month by -5.04%, over three months by +19.21% and over the past year by -1.77%.
Current recommended Stop Loss: 21.40 (which is 6.6% or 1.3 ATR below the current price).
HP has received a consensus analysts rating of 3.24. Therefore, it is recommended to hold HPQ.
- StrongBuy: 2
- Buy: 2
- Hold: 12
- Sell: 0
- StrongSell: 1
| Analysts Target Price | 22.9 | -0% |
P/E Trailing = 8.7037
P/E Forward = 7.8309
P/S = 0.3743
P/B = 0.6074
P/EG = 19.5833
Revenue TTM = 57.4b USD
EBIT TTM = 3.07b USD
EBITDA TTM = 3.92b USD
Long Term Debt = 8.86b USD (from longTermDebt, last quarter)
Short Term Debt = 810.0m USD (from shortTermDebt, last quarter)
Debt = 10.9b USD (from shortLongTermDebtTotal, last quarter) + Leases 1.20b
Net Debt = 7.16b USD (calculated: Debt 10.9b - CCE 3.70b)
Enterprise Value = 28.7b USD (21.5b + Debt 10.9b - CCE 3.70b)
Interest Coverage Ratio = 6.77 (Ebit TTM 3.07b / Interest Expense TTM 454.0m)
EV/FCF = 7.58x (Enterprise Value 28.7b / FCF TTM 3.78b)
FCF Yield = 13.19% (FCF TTM 3.78b / Enterprise Value 28.7b)
FCF Margin = 6.58% (FCF TTM 3.78b / Revenue TTM 57.4b)
Net Margin = 4.45% (Net Income TTM 2.55b / Revenue TTM 57.4b)
Gross Margin = 20.31% ((Revenue TTM 57.4b - Cost of Revenue TTM 45.8b) / Revenue TTM)
Gross Margin QoQ = 20.93% (prev 19.64%)
Tobins Q-Ratio = 0.67 (Enterprise Value 28.7b / Total Assets 42.9b)
Interest Expense / Debt = 4.18% (Interest Expense 454.0m / Debt 10.9b)
Taxrate = 2.63% (69.0m / 2.62b)
NOPAT = 2.99b (EBIT 3.07b * (1 - 2.63%))
Current Ratio = 0.79 (Total Current Assets 24.0b / Total Current Liabilities 30.2b)
Debt / Equity = -75.44 (negative equity) (Debt 10.9b / totalStockholderEquity, last quarter -144.0m)
Debt / EBITDA = 1.83 (Net Debt 7.16b / EBITDA 3.92b)
Debt / FCF = 1.89 (Net Debt 7.16b / FCF TTM 3.78b)
Total Stockholder Equity = -539.2m (last 4 quarters mean from totalStockholderEquity)
RoA = 6.25% (Net Income 2.55b / Total Assets 42.9b)
RoE = -473.4% (negative equity) (Net Income TTM 2.55b / Total Stockholder Equity -539.2m)
RoCE = 36.96% (EBIT 3.07b / Capital Employed (Equity -539.2m + L.T.Debt 8.86b))
RoIC = 28.05% (NOPAT 2.99b / Invested Capital 10.7b)
WACC = 8.29% (E(21.5b)/V(32.4b) * Re(10.43%) + D(10.9b)/V(32.4b) * Rd(4.18%) * (1-Tc(0.03)))
Discount Rate = 10.43% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -98.88 | Cagr: -3.49%
[DCF] Terminal Value 77.97% ; FCFF base≈3.33b ; Y1≈3.82b ; Y5≈5.62b
[DCF] Fair Price = 84.64 (EV 84.6b - Net Debt 7.16b = Equity 77.4b / Shares 914.5m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: -45.92 | EPS CAGR: -1.50% | SUE: 3.64 | # QB: 2
Revenue Correlation: 75.03 | Revenue CAGR: 2.04% | SUE: 2.31 | # QB: 2
EPS current Quarter (2026-07-31): EPS=0.66 | Chg30d=+4.86% | Revisions=+43% | Analysts=12
EPS current Year (2026-10-31): EPS=3.02 | Chg30d=+4.66% | Revisions=+68% | GrowthEPS=-3.3% | GrowthRev=+4.4%
EPS next Year (2027-10-31): EPS=3.01 | Chg30d=+1.42% | Revisions=+11% | GrowthEPS=-0.2% | GrowthRev=-0.1%
[Analyst] Revisions Ratio: +68%